WuXi Biologics Wins Six Awards at 2026 Asia-Pacific Biopharma Excellence Awards
WuXi Biologics received six awards and two individual leadership honors at the 2026 Asia-Pacific Biopharma Excellence Awards, marking a record for the company. The awards highlight its leadership in biologics development, manufacturing, and digital innovation. Notable awards include Best Contract Development & Manufacturing Organization and Excellence in Bioprocessing Automation & Digitalization. Dr. Sherry Gu was named CTO of the Year, and Dr. Jeremy Guo received Head of Fill-Finish & Formulation of the Year.
Theia Market Signal Identification - AI Assisted
WuXi Biologics won six awards at the 2026 Asia-Pacific Biopharma Excellence Awards, achieving a record for the most awards received in a single year. The company was recognized in categories such as Best Contract Development & Manufacturing Organization and Excellence in Bioprocessing Automation & Digitalization.
Dr. Sherry Gu was honored as CTO of the Year for her leadership in biologics development, while Dr. Jeremy Guo received the award for Head of Fill-Finish & Formulation of the Year. These accolades reflect WuXi's commitment to quality and innovation in bioprocessing and manufacturing.
Comments